Investors Buy High Volume of Call Options on agilon health (NYSE:AGL)

agilon health, inc. (NYSE:AGLGet Free Report) was the recipient of some unusual options trading on Friday. Investors acquired 6,103 call options on the stock. This represents an increase of approximately 471% compared to the average daily volume of 1,069 call options.

agilon health Stock Up 10.1 %

AGL stock opened at $4.51 on Friday. The company has a market cap of $1.86 billion, a price-to-earnings ratio of -4.80 and a beta of 0.67. The firm has a 50-day moving average of $3.51 and a two-hundred day moving average of $2.95. agilon health has a 12 month low of $1.50 and a 12 month high of $7.73. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

Institutional Investors Weigh In On agilon health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Point72 Asia Singapore Pte. Ltd. purchased a new stake in agilon health in the 3rd quarter valued at $28,000. Oak Thistle LLC purchased a new stake in shares of agilon health in the fourth quarter valued at about $25,000. Ieq Capital LLC purchased a new stake in shares of agilon health in the fourth quarter valued at about $26,000. Signaturefd LLC increased its position in agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock worth $27,000 after purchasing an additional 8,467 shares during the last quarter. Finally, Humankind Investments LLC purchased a new position in agilon health during the fourth quarter worth about $30,000.

Analyst Ratings Changes

A number of equities analysts have issued reports on AGL shares. Royal Bank of Canada increased their price target on agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research report on Wednesday, February 26th. Sanford C. Bernstein increased their target price on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research report on Wednesday, January 15th. Stifel Nicolaus boosted their price target on shares of agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a report on Wednesday, February 26th. Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and upped their price objective for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Finally, Macquarie initiated coverage on shares of agilon health in a research report on Monday, December 16th. They issued a “neutral” rating and a $3.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, agilon health currently has an average rating of “Hold” and an average target price of $3.95.

Read Our Latest Stock Analysis on agilon health

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Further Reading

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.